provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrugsSumatriptan

4 Sumatriptan Interactions to Watch Out for

Austin Ulrich, PharmD, BCACPJoshua Murdock, PharmD, BCBBS
Published on September 23, 2022

Key takeaways:

  • Sumatriptan is part of a group of medications called triptans. It treats moderate to severe migraines. It’s available in many forms, including a tablet (Imitrex) and nasal spray (Tosmyra).

  • Sumatriptan raises serotonin levels. It can interact with other medications that raise serotonin levels. This includes many antidepressants, tramadol (Ultram, ConZip), and linezolid (Zyvox). 

  • Sumatriptan can tighten your blood vessels and raise your blood pressure. It shouldn’t be used with other triptans or a class of medications called ergot derivatives. The combination could lead to dangerously high blood pressure.

Access savings on related medications

Close-up woman with pack of pills and smartphone in hand
bondarillia/iStock via Getty Images Plus

Sumatriptan belongs to a group of medications called triptans. It’s a first-choice medication for moderate to severe migraine attacks. It can also be used for mild attacks that don’t respond to medications like nonsteroidal anti-inflammatory drugs (NSAIDs). 

Sumatriptan comes in multiple forms. This includes an oral tablet (Imitrex) and an injection (Imitrex Statdose, Zembrace SymTouch, Imitrex). It also comes as a nasal spray (Tosmyra, Imitrex) and nasal powder (Onzetra Xsail). But like all medications, it comes with some risks. This includes drug interactions with other medications. Below we’ll discuss several interactions to consider if you’re taking sumatriptan.

But keep in mind this isn’t a complete list. Always check with your healthcare provider and pharmacist before taking sumatriptan. Give them an updated list of all your medications. This will help them to check for possible sumatriptan interactions. 

Promotion disclosure
Avg retail price
$139.57(Save 92.55%)
GoodRx discount
$10.40

1. Monoamine oxidase inhibitors

Monoamine oxidase inhibitors (MAOIs) treat various medical conditions. Examples include depression and Parkinson’s disease. But they have many side effects and possible drug interactions. They also require certain dietary restrictions while taking them. Examples of MAOIs include selegiline (Zelapar, Emsam) and methylene blue.

Monoamine oxidase is an enzyme (protein) that’s naturally present in the body. It metabolizes (breaks down) different chemicals in the brain. It also metabolizes sumatriptan

MAOIs can interact with sumatriptan. This is because MAOIs prevent monoamine oxidase from working as it normally would. When monoamine oxidase is less active, sumatriptan levels can build up in the body. 

Higher sumatriptan levels make it more likely to have side effects. This could include tingling sensations, chest pain or pressure, and fatigue. It could also include more serious side effects. These include heart rhythm changes, seizures, or stroke.

Sumatriptan (and other triptans) shouldn’t be taken with MAOIs. If you’re taking an MAOI, you should stop taking it at least 2 weeks before starting sumatriptan. If stopping your MAOI isn't an option, talk to your healthcare provider. They may recommend a different migraine medication.

2. Medications that raise serotonin levels

Serotonin is a chemical in your brain. It helps regulate many body functions. This includes managing your emotions, memory, and sleep. Many medications raise serotonin levels, including sumatriptan. 

Serotonin syndrome is a rare but serious condition of too much serotonin in the brain. It’s caused by medications that increase serotonin levels. It’s unlikely to happen if you’re taking only one medication that affects serotonin at a usual dose. Most cases of serotonin syndrome happen when people take large doses of multiple medications that increase serotonin levels. Examples of medications that increase serotonin include:

Serotonin syndrome is usually mild. Mild symptoms of serotonin syndrome include sweating, faster heartbeat, and tremors. If you experience any of these symptoms, talk to your healthcare provider. They may tell you to stop taking medications that increase serotonin. But don’t do this without talking to your provider first. Some of these medications shouldn’t be stopped abruptly.

Unfortunately, symptoms can be more serious, too. Examples include a high fever, dangerously high blood pressure, and uncontrollable body movements. You should seek immediate medical care if you have any of these symptoms.

If you take one of the medications mentioned above, talk to your healthcare provider before starting sumatriptan. They may just recommend watching for signs of serotonin syndrome while taking sumatriptan. Or they may recommend another migraine medication. 

3. Ergot derivatives

Ergot derivatives are a broad group of medications that treat many medical conditions. This includes migraines, Parkinson’s disease, and hyperprolactinemia.  Examples of ergot derivatives include dihydroergotamine (Migranal, Trudhesa) and ergotamine (Ergomar).

Ergot derivatives affect multiple hormones and chemicals in the body. One effect of many ergot derivatives is the tightening of blood vessels. This is called vasoconstriction, and it can increase your blood pressure. 

Sumatriptan can also cause vasoconstriction and high blood pressure. The risk is greater if sumatriptan is combined with ergot derivatives. In serious cases, excessive vasoconstriction could potentially lead to a heart attack or stroke.

Avoid taking sumatriptan (or any triptan) within 24 hours of ergot medications. If you have any questions about this risky combination, talk to your healthcare provider. They can talk to you about why this combination isn’t a good idea, and how to best manage your migraines.

4. Other triptan medications

Sumatriptan and other triptans treat migraines by tightening blood vessels in the brain. They also block pain signals in the brain. Examples besides sumatriptan include rizatriptan (Maxalt, Maxalt-MLT) and zolmitriptan (Zomig, Zomig-ZMT).

The risk of combining other triptans with sumatriptan is similar to ergot derivatives. It could cause very high blood pressure, a heart attack, or a stroke.

You shouldn’t combine sumatriptan with other triptans. If you’re switching from one triptan to another, wait 24 hours before starting the new triptan. If you need pain relief in the meantime, talk to your healthcare provider. They may recommend NSAIDs or acetaminophen (Tylenol).

It’s important to mention that it is possible to combine different forms of the same medication. For example, your healthcare provider may recommend sumatriptan nasal spray and tablets in some cases (taken at least 1 hour apart).

The bottom line

Sumatriptan is part of a group of medications called triptans. It treats moderate to severe migraine attacks. It comes in many forms, which can make it convenient to use. But it can have several drug interactions. For example, it can interact with medications and substances that raise serotonin levels. This includes multiple antidepressants, tramadol, and St. John’s wort. 

Sumatriptan shouldn’t be taken within 2 weeks of an MAOI. And it shouldn’t be taken within 24 hours of ergot derivatives (like dihydroergotamine) or other triptans (like rizatriptan). 

why trust our exports reliability shield

Why trust our experts?

Austin Ulrich, PharmD, BCACP
Austin Ulrich, PharmD, BCACP, is a board-certified ambulatory care clinical pharmacist. In his early career, he provided direct patient care in a variety of settings, including hospital and community pharmacies, and in a primary care clinic as a clinical pharmacist.
Amy B. Gragnolati, PharmD, BCPS
Amy Gragnolati, PharmD, BCPS, is a pharmacy editor for GoodRx. Amy currently holds her pharmacist license in Georgia and California.
Joshua Murdock, PharmD, BCBBS
Joshua Murdock, PharmD, BCBBS, is a licensed pharmacist in Arizona, Colorado, and Rhode Island. He has worked in the pharmacy industry for more than 10 years and currently serves as a pharmacy editor for GoodRx.

References

Ailani, J., et al. (2021). The American Headache Society consensus statement: Update on integrating new migraine treatments into clinical practice. Headache: The Journal of Head and Face Pain.

Laban, S. T., et al. (2022). Monoamine oxidase inhibitors (MAOI). StatPearls.

View All References (3)

Nicolas, S., et al. (2022). Triptans. StatPearls.

Quality Care Products, LLC. (2022). Sumatriptan [package insert].

Schiff, P. L. (2006). Ergot and its alkaloids. American Journal of Pharmaceutical Education.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.